Skip to main content
Premium Trial:

Request an Annual Quote

Affy Clinical Services, DOCRO Pen Deal to Help Customers Advance Their IVDs

NEW YORK (GenomeWeb News) — Affymetrix’s Clinical Services Laboratory and IVD contract research company DOCRO have formed a partnership to help pharmaceutical companies, IVD makers, and other customers move their products toward clearance by the US Food and Drug Administration, Affymetrix said today.
 
Affy said the agreement offers its ACSL customers validation and clinical trial services such as protocol design, patient recruitment, clinical site training and monitoring, sample procurement, device testing, and guidance for the submission process.
 
Affy said DOCRO will supply its ACSL customers “a clear path and understanding of how to commercialize IVD products.”

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.